KRAS NP_004976.2:P.G12D

Clinical trials for KRAS NP_004976.2:P.G12D explained in plain language.

Never miss a new study

Get alerted when new KRAS NP_004976.2:P.G12D trials appear

Sign up with your email to follow new studies for KRAS NP_004976.2:P.G12D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test 'Smart Package' therapy to target deadly pancreatic cancer

Disease control Recruiting now

This early-phase trial is testing a new treatment for advanced pancreatic cancer that has spread and carries a specific genetic change (KRAS G12D mutation). The treatment uses tiny natural packages from cells (called exosomes) to deliver a gene-silencing drug directly to the canc…

Matched conditions: KRAS NP_004976.2:P.G12D

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

KRAS NP_004976.2:P.G12D

Get alerted when new KRAS NP_004976.2:P.G12D trials appear

Scientists test 'Smart Package' therapy to target deadly pancreatic cancer